Early Identification of Severe COVID-19 Cases and the Need for ICU Care Based on Clinical and Laboratory Risk Factors

May 17, 2025 | John Murphy | Leave a Comment

Early Identification of Severe COVID-19 Cases and the Need for ICU Care Based on Clinical and Laboratory Risk Factors

Jawad Mahmood • Muhammad Izhar Ul Haque • Maria Gul • Aliya Ayub • Fawwad A. Ansari • Wiqas Ahmad DOI: 10.7759/cureus.80611 Abstract Background and objective Treatment in ICUs became extremely difficult due to the growing number of coronavirus disease 2019…[...]

March 26, 2025 | John Murphy | Leave a Comment

D-dimer as a Predictor of ICU Admission and Mortality in COVID-19 Patients: Insights From a Two-Year Retrospective Study

Abstract Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced pneumonitis results in a prothrombotic and hypercoagulable state. Prognostic indicators are crucial for identifying patients at risk of complications. D-dimer, a…[...]

January 4, 2025 | John Murphy | Leave a Comment

5 things we know and still don’t know about COVID, 5 years after it appeared

By LAURAN NEERGAARD, and MIKE STOBBE Five years ago, a cluster of people in Wuhan, China, fell sick with a virus never before seen in the world. The germ didn’t have a name,…[...]

September 28, 2024 | John Murphy | Leave a Comment

Three-year outcomes of post-acute sequelae of COVID-19

Miao Cai, , Yan Xie, Eric J. Topol & Ziyad Al-Aly Nature Medicine volume 30, pages1564–1573 (2024) Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC) in many organ…[...]

November 15, 2023 | John Murphy | Leave a Comment

Ventilator-associated pneumonia in ICU patients with severe pneumonia and respiratory failure

Sarah Jackson Published June 15, 2023 - 10.1172/JCI172643 The Journal of Clinical Medicine The COVID-19 pandemic resulted in an unprecedented number of patients hospitalized in intensive care units (ICUs) because of…[...]

November 14, 2023 | John Murphy | Leave a Comment

COVID-19 Therapeutics for Nonhospitalized Patients

Rajesh T. Gandhi, MD1; Preeti N. Malani, MD, MSJ2,3; Carlos del Rio, MD4, JAMA. 2022;327(7):617-618. doi:10.1001/jama.2022.0335 Substantial progress has been made in therapeutics for nonhospitalized patients with COVID-19, but supply of and access to treatment remain limited. This Viewpoint…[...]

November 9, 2023 | John Murphy | Leave a Comment

FDA, CDC Hid Data On Spike In COVID Cases Among The Vaccinated: Documents

SEP 2023 - Authored by Zachary Stieber The Epoch Times COVID-19 cases among vaccinated seniors soared in 2021, according to newly disclosed data that was acquired by U.S. health agencies…[...]

November 4, 2023 | John Murphy | Leave a Comment

Hydroxychloroquine Associated With Lower COVID-19 Mortality: Study

The French study included 30,202 patients. Zachary Stieber, 11/3/2023 Epoch Health People who received hydroxychloroquine were less likely to die than those who did not, according to a new study. Just…[...]

November 1, 2023 | John Murphy | Leave a Comment

Study Deems Popular COVID Treatment ‘Ineffective,’ Sometimes ‘Harmful’

The often debated treatment did not improve outcomes in critically ill patients Published 10/27/23, Hannah Murphy, The Messenger High doses of intravenous vitamin C are no more effective than a…[...]

October 26, 2023 | John Murphy | Leave a Comment

Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza

Vincent Zhang, Molly Fisher,Wei Hou,Lili Zhang and Tim Q. Duong Aug 2023 https://doi.org/10.1161/HYPERTENSIONAHA.123.21174 Hypertension. 2023;0 Abstract BACKGROUND: SARS-CoV-2 may trigger new-onset persistent hypertension. This study investigated the incidence and risk factors associated…[...]